Home
Network
Publications
Training
Documents
News
Contact

Menu

Home
Network
Publications
Training
Documents
News
Contact

Search

Close

Posted on April 26, 2019May 6, 2019 by adminclonal

Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis

CategoriesOliver SoehnleinTagsde Jong R, Drechsler M, Hidalgo A, Hristov M, Immler R, Lemnitzer P, Nicolaes GAF, Ortega-Gomez A, Poelman H, Scheiermann C, Schumski A, Silvestre-Roig C, Soehnlein O. Cell Metab, Sperandio M, Viola JR, Weber C, Winter C, Winter J, Zeller T

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Please enter an answer in digits:

one × 3 =

Post navigation

Previous PostPrevious Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation

Next PostNext Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

This research is supported by a grant from the Fondation Leducq All rights reserved. 2019 Clonal Hematopohiesis and Atherosclerosis info@clonal-hematopoiesis-leducq.com

Top